On the stock market since 1981, it operates in the world of money and finance. It has 443 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Revenue is spread across several business lines; no single line carries the company.
No real growth. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades 22% below its peak. The market has trimmed its expectations for the company.
Sales run at $485.5M a year. A small number, but proof the product has real buyers.
It pays out $0.64 per share each year — regular cash for whoever holds the stock.
A loss of $20.8M against $485.5M in annual sales. And on top of that, sales fell from the year before.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, KCLI sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: KCLI is a high-risk stock — not yet profitable, and its future rides on its product catching on.